Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Vaccine Safety Datalink (VSD) Project Publications

Averhoff F, Zucker J, Vellozzi C et al. Adequacy of surveillance to detect endemic rubella transmission in the United States. Clin Infect Dis. 2006;43(Suppl 3):S151-S157.

Baggs J, Gee J, Lewis E et al. The Vaccine Safety Datalink: a model for monitoring immunization safety. Pediatrics. 2011;127(Supp 1):S45-S53.

Barile JP, Kuperminc GP, Weintraub ES et al. Thimerosal exposure in early life and neuropsychological outcomes 7-10 years later. J Pediatr Psychol. 2011;37(1):106-118.

Barlow W. Measurement of interrater agreement with adjustment for covariates. Biometrics. 1996;52(2):695-702. (Abstract only)

Barlow WE, Davis RL, Glasser JW et al. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med. 2001;345(9):656-661.

Barlow WE. Global measures of local influence for proportional hazards regression models. Biometrics. 1997;53(3):1157-1162. (Abstract only)

Batra JS, Eriksen EM, Zangwill KM et al. Evaluation of vaccine coverage for low birth weight infants during the first year of life in a large managed care population. Pediatrics. 2009;123(3):951-958.

Baxter R, Bakshi N, Fireman B et al. Lack of association of Guillain-Barré syndrome with vaccinations. Clin Infect Dis. 2013; 57(2):197-204. (Abstract only)

Belay ED, Holman RC, Clarke MJ et al. The incidence of Kawasaki syndrome in West Coast health maintenance organizations. Pediatr Infect Dis J. 2000;19(9):828-832. (Abstract only)

Belongia EA, Irving SA, Shui IM et al. Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatr Infect Dis J. 2010;29(1):1-5. (Abstract only)

Top of Page

Belongia EA, Naleway A, Kieke B et al. Validation of a screening instrument to identify persons for exclusion from smallpox vaccination. Clin Infect Dis. 2005;40(4):620-623.

Benson PJ, Jackson LA, Rees TG, Dunn JB. Changes in DT vaccine frequency and indications for use following introduction of DTaP vaccine. Hum Vaccin. 2008;4(3):234-237. [PDF - 138 KB]

Black S, Shinefield H, Ray P et al. Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children: an analysis of the Vaccine Safety Datalink (VSD) Project. Pediatr Infect Dis J. 1997;16(5):500-503. (Abstract only)

Black SB, Shinefield HR, France EK et al. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am J Perinatol. 2004;21(6):333-339. (Abstract only)

Black SB, Lewis E, Shinefield HR et al. Lack of association between receipt of conjugate haemophilus influenzae type B vaccine (HbOC) in infancy and risk of type 1 (juvenile onset) diabetes: long term follow-up of the HbOC efficacy trial cohort. Pediatr Infect Dis J. 2002;21(6):568-569. (Abstract only)

Bohlke K, Davis RL, DeStefano F et al. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J Allergy Clin Immunol. 2004;113(3):536-542. (Abstract only)

Bohlke K, Davis RL, Marcy SM et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics. 2003;112(4):815-820. (Abstract only)

CDC. Update: Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June 2005-September 2006. MMWR Morb Mortal Wkly Rep. 2006;55(41):1120-1124.

CDC. Update: Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, October 2005-February 2006. MMWR Morb Mortal Wkly Rep. 2006;55(13):364-366.

Chang EJ, Zangwill KM, Lee H, Ward JI. Lack of association between rotavirus infection and intussusception: implications for use of attenuated rotavirus vaccines. Pediatr Infect Dis J. 2002;21(2):97-102. (Abstract only)

Top of Page

Chen RT, DeStefano F, Pless R et al. Challenges and controversies in immunization safety. Infect Dis Clin North Am. 2001;15(1):21-39, viii. (Abstract only)

Chen RT, DeStefano F, Davis RL et al. The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA. Bull World Health Organ. 2000;78(2):186-194. [PDF - 313 KB]

Chen RT, Glasser JW, Rhodes PH et al. Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. Pediatrics. 1997;99(6):765-773. (Abstract only)

Chen RT, Mootrey G, DeStefano F. Safety of routine childhood vaccinations: an epidemiological review. Paediatr Drugs 2000; 2:273-290. (Abstract only)

Clayton HA, Cortes MM, Payne DC et al. Rotavirus vaccination coverage and adherence to the Advisory Committee on Immunization Practices (ACIP)-recommended vaccination schedule--United States, February 2006-May 2007. MMWR Morb Mortal Wkly Rep. 2008;57(15):398-401.

Daley MF, Yih WK, Glanz JM et al. Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. Vaccine. 2014;32(25):3019-3024. (Abstract only)

Davis RL, Kolczak M, Lewis E et al. Active surveillance of vaccine safety: a system to detect early signs of adverse events. Epidemiology. 2005;16(3):336-341. (Abstract only)

Davis RL, Lieu TA, Mell LK et al. Impact of the change in polio vaccination schedule on immunization coverage rates: a study in two large health maintenance organizations. Pediatrics. 2001;107(4):671-676. (Abstract only)

Davis RL, Kramarz P, Bohlke K et al. Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project. Arch Pediatr Adolesc Med. 2001;155(3):354-359.

Davis RL, Bohlke K. Measles vaccination and inflammatory bowel disease: controversy laid to rest? Drug Saf. 2001;24(13):939-946. (Abstract only)

Top of Page

Davis RL, Rubanowice D, Shinefield HR et al. Immunization levels among premature and low-birth-weight infants and risk factors for delayed up-to-date immunization status. JAMA. 1999;282(6):547-553. (Abstract only)

Davis RL, Mell LK, Zavitkovsky A et al. Impact of the sequential IPV/OPV schedule on vaccination coverage levels--United States, 1997. MMWR Morb Mortal Wkly Rep. 1998;47(47):1017-1019.

Davis RL, Marcuse E, Black S et al. MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunization in the Vaccine Safety Datalink project. Pediatrics. 1997;100(5):767-771. (Abstract only)

Davis RL, Black S, Vadheim C et al. Immunization tracking systems: experience of the CDC Vaccine Safety Datalink sites. HMO Pract. 1997;11(1):13-17. (Abstract only)

DeStefano F, Price CS, Weintraub ES. Increasing exposure to antibody-stimulating proteins and polysaccharides in vaccines is not associated with risk of autism. J Pediatr. 2013;163(2):561-567. (Abstract only)

DeStefano F, Weintraub ES, Chen RT. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study. Neurology. 2005;64(7):1317. (Abstract only)

DeStefano F, Verstraeten T, Jackson LA et al. Vaccinations and risk of central nervous system demyelinating diseases in adults. Arch Neurol. 2003;60(4):504-509. http://archneur.ama,

DeStefano F, Gu D, Kramarz P et al. Childhood vaccinations and risk of asthma. Pediatr Infect Dis J. 2002;21(6):498-504. (Abstract only)

DeStefano F, Verstraeten T, Chen RT. Hepatitis B vaccine and risk of multiple sclerosis. Expert Rev Vaccines. 2002;1(4):461-466. (Abstract only)

DeStefano F, Mullooly JP, Okoro CA et al. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics. 2001;108(6):E112. (Abstract only)

Top of Page

DeStefano F. The Vaccine Safety Datalink project. Pharmacoepidemiol Drug Saf. 2001;10(5):403-406. (Abstract only)

DeStefano F. Opportunities for population-based clinical research using data from managed care organizations. In: Davis JR, ed. Managed Care Systems and Emerging Infections. Washington, D.C.: National Academy Press, 2000: 16-18.

DeStefano F, Chen RT. Negative association between MMR and autism. Lancet. 1999;353(9169):1987-1988. (No abstract available)

Dodd CN, Romio SA, Black S et al. International collaboration to assess the risk of Guillain Barre Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine. 2013;31(40):4448-4458. (Abstract only)

Donahue JG, Kieke BA, Gargiullo PM et al. Herpes zoster and exposure to the varicella zoster virus in an era of varicella vaccination. Am J Public Health. 2010;100(6):1116-1122.

Donahue JG, Kieke BA, Yih WK et al. Varicella vaccination and ischemic stroke in children: is there an association? Pediatrics. 2009;123(2):e228-e234.

Duffy J, Weintraub, E, Vellozzi, C, DeStefano F. Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States. Neurology. 2014;83(20):1823-30.

Eriksen EM, Perlman JA, Miller A et al. Lack of association between hepatitis B birth immunization and neonatal death: a population-based study from the vaccine safety datalink project. Pediatr Infect Dis J. 2004;23(7):656-662. (Abstract only)

France EK, Glanz J, Xu S et al. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics. 2008;121(3):e687-e692.

France EK, Smith-Ray R, McClure D et al. Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants. Arch Pediatr Adolesc Med. 2006;160(12):1277-1283.

France EK, Glanz JM, Xu S et al. Safety of the trivalent inactivated influenza vaccine among children: a population-based study. Arch Pediatr Adolesc Med. 2004;158(11):1031-1036.

Top of Page

Gargiullo PM, Kramarz P, DeStefano F, Chen RT. Principles of epidemiological research on drug effects. [Letter] Lancet. 1999;353(9151):501.

Gee J, Naleway A, Shui I et al. Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink. Vaccine. 2011;29(46):8279-8284. (Abstract only)

Glanz J, France E, Xu S et al. A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children. Pediatrics. 2008;121(3):e506-e512.

Glanz JM, Narwaney KJ, Newcomer SR et al. Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age. JAMA Pediatr. 2013;167(11):1060-1064. (Abstract only)

Glanz JM, Newcomer SR, Narwaney KJ et al. A population-based cohort study of undervaccination in 8 managed care organizations across the United States. JAMA Pediatr. 2013;167(3):274-281. (Abstract only)

Glanz JM, Newcomer SR, Hambidge SJ et al. Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the Vaccine Safety Datalink. Arch Pediatr Adolesc Med. 2011;165(8):749-755. (Abstract only)

Glanz JM, McClure DL, Xu S et al. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations. J Clin Epidemiol. 2006;59(8):808-818. (Abstract only)

Gold R, Naleway A, Riedlinger K. Factors predicting completion of the human papillomavirus vaccine series. J Adolesc Health. 2013;52(4):427-432. (Abstract only)

Gonzalez IM, Averhoff FM, Massoudi MS et al. Hepatitis B vaccination among adolescents in 3 large health maintenance organizations. Pediatrics. 2002;110(5):929-934. (Abstract only)

Goodman MJ, Nordin JD, Belongia EA et al. Henöch-Schonlein purpura and polysaccharide meningococcal vaccine. Pediatrics. 2010;126(2):e325-e329.

Top of Page

Greene SK, Li L, Shay DK, et al. Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010. Pharmacoepidemiol Drug Saf. 2013;22(4):335-344. (Abstract only)

Greene SK, Rett MD, Vellozzi C, et al. Guillain-Barre syndrome, influenza vaccination, and antecedent respiratory and gastrointestinal infections: a case-centered analysis in the Vaccine Safety Datalink, 2009-2011. PLoS One. 2013;8(6):e67185.

Greene SK, Rett M, Weintraub ES, et al. Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink project, 2009-2010. Am J Epidemiol. 2012;175(11):1100-1109.

Greene SK, Shay DK, Yin R, et al. Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010. Influenza Other Respir Viruses. 2012;6(6):e143-e151. (Abstract only)

Greene SK, Kulldorff M, Yin R, et al. Near real-time vaccine safety surveillance with partially accrued data. Pharmacoepidemiol Drug Saf. 2011;20(6):583-590. (Abstract only)

Greene SK, Kulldorff M, Lewis EM et al. Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink project. Am J Epidemiol. 2010;171(2):177-188.

Greene SK, Shi P, Dutta-Linn MM et al. Accuracy of data on influenza vaccination status at four Vaccine Safety Datalink sites. Am J Prev Med. 2009;37(6):552-555. (Abstract only)

Haber P, Patel M, Izurieta HS, et al. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics. 2008;121(6):1206-1212.

Hambidge SJ, Newcomer SR, Narwaney KJ, et al. Timely versus delayed early childhood vaccination and seizures. Pediatrics. 2014;133(6):e1492-e1499.

Hambidge SJ, Ross C, Glanz J, et al. Trivalent inactivated influenza vaccine is not associated with sickle cell crises in children. Pediatrics. 2012;129(1):e54-e59.

Hambidge SJ, Ross C, McClure D, et al. Trivalent inactivated influenza vaccine is not associated with sickle cell hospitalizations in adults from a large cohort. Vaccine. 2011;29(46):8179-8181. (Abstract only)

Hambidge SJ, Glanz JM, France EK, et al. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. JAMA. 2006;296(16):1990-1997. (Abstract only)

Harris K, Baggs J, Davis RL, et al. Influenza vaccination coverage among adult solid organ transplant recipients at three health maintenance organizations, 1995-2005. Vaccine. 2009;27(17):2335-2341. (Abstract only)

Hazlehurst B, Naleway A, Mullooly J. Detecting possible vaccine adverse events in clinical notes of the electronic medical record. Vaccine. 2009;27(14):2077-2083. (Abstract only)

Hazlehurst B, Mullooly J, Naleway A, et al. Detecting possible vaccination reactions in clinical notes. AMIA Annu Symp Proc. 2005:306-310.

Hechter RC, Qian L, Sy LS, et al. Secular trends in diagnostic code density in electronic healthcare data from health care systems in the Vaccine Safety Datalink project. Vaccine. 2012;31(7):1080-1085. (Abstract only)

Heffelfinger JD, Heckbert SR, Psaty BM, et al. Influenza vaccination and risk of incident myocardial infarction. Hum Vaccin. 2006;2(4):161-166.

Henninger M, Crane B, Naleway A. Trends in influenza vaccine coverage in pregnant women, 2008 to 2012. Perm J. 2013;17(2):31-36.

Henninger M, Naleway A, Crane B, et al. Predictors of seasonal influenza vaccination during pregnancy. Obstet Gynecol. 2013;121(4):741-749. (Abstract only)

Hinrichsen VL, Kruskal B, O'Brien MA, et al. Using electronic medical records to enhance detection and reporting of vaccine adverse events. J Am Med Inform Assoc. 2007;14(6):731-735.

Top of Page

Huang WT, Gargiullo PM, Broder KR, et al. Lack of association between acellular pertussis vaccine and seizures in early childhood. Pediatrics. 2010;126(2):263-269.

Iqbal S, Barile JP, Thompson WW, et al. Number of antigens in early childhood vaccines and neuropsychological outcomes at age 7-10 years. Pharmacoepidemiol Drug Saf. 2013;22(12):1263-1270. (Abstract only)

Irving SA, Kieke BA, Donahue JG, et al. Trivalent inactivated influenza vaccine and spontaneous abortion. Obstet Gynecol. 2013;121(1):159-165. (Abstract only)

Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342(4):232-239.

Jackson ML, Yu O, Nelson JC, et al. Further evidence for bias in observational studies of influenza vaccine effectiveness: the 2009 influenza A(H1N1) pandemic. Am J Epidemiol. 2013;178(8):1327-1336. (Abstract only)

Jackson LA, Peterson D, Nelson JC, et al. Vaccination site and risk of local reactions in children 1 through 6 years of age. Pediatrics. 2013;131(2):283-289.

Jackson LA, Yu O, Nelson JC, et al. Injection site and risk of medically attended local reactions to acellular pertussis vaccine. Pediatrics. 2011;127(3):e581-e587.

Jackson LA, Peterson D, Dunn J, et al. A randomized placebo-controlled trial of acetaminophen for prevention of post-vaccination fever in infants. PLoS One. 2011;6(6):e20102.

Jackson LA, Baxter R, Naleway AL, et al. Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study. BMC Infect Dis. 2009;9:37.

Jackson LA, Yu O, Belongia EA, et al. Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study. BMC Infect Dis. 2009;9:165.

Top of Page

Jackson LA, Yu O, Nelson J, et al. Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: a Vaccine Safety Datalink study. Vaccine. 2009;27(36):4912-4916. (Abstract only)

Jackson ML, Nelson JC, Chen RT, et al. Vaccines and changes in coagulation parameters in adults on chronic warfarin therapy: a cohort study. Pharmacoepidemiol.Drug Saf. 2007;16(7):790-796. (Abstract only)

Jackson LA, Neuzil KM, Nahm MH, et al. Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide-protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. Vaccine. 2007;25(20):4029-4037. (Abstract only)

Jackson LA, Nelson JC, Whitney CG, et al. Assessment of the safety of a third dose of pneumococcal polysaccharide vaccine in the Vaccine Safety Datalink population. Vaccine. 2006;24(2):151-156. (Abstract only)

Jackson LA, Neuzil KM, Baggs J, et al. Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time: a Vaccine Safety Datalink study. Pediatrics. 2006;118(5):2032-2037.

Jackson LA, Neuzil KM, Whitney CG, et al. Safety of varying dosages of 7-valent pneumococcal protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. Vaccine. 2005;23(28):3697-3703. (Abstract only)

Jackson LA, Neuzil KM, Yu O, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med. 2003;348(18):1747-1755.

Jackson LA, Yu O, Heckbert SR, et al. Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events. Am J Epidemiol. 2002;156(7):634-640.

Jackson LA, Austin G, Chen RT, et al. Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors. Vaccine. 2001;19(32):4703-4709. (Abstract only)

Jackson LA, Benson P, Sneller VP, et al. Safety of revaccination with pneumococcal polysaccharide vaccine. JAMA. 1999;281(3):243-248. (Abstract only)

Top of Page

Kawai AT, Li L, Kulldorff M, et al. Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barre syndrome, encephalitis, or anaphylaxis in the 2012-2013 season. Pharmacoepidemiol Drug Saf. 2014;23(5):548-553. (Abstract only)

Kharbanda Eo, Vazquez-Benitez G, Lipkind HS, et al. Evaluation of the Association of Maternal Pertussis Vaccination With Obstetric Events and Birth Outcomes. JAMA. 2014;312(18):1897-1904.

Kharbanda EO, Vazquez-Benitez G, Lipkind H et al. Receipt of pertussis vaccine during pregnancy across 7 Vaccine Safety Datalink sites. Prev Med. [online ahead of print 2014 June 18]. (Abstract only)

Kharbanda EO, Vazquez-Benitez G, Lipkind H, et al. Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events. Obstet Gynecol. 2013;122(3):659-667. (Abstract only)

Kharbanda EO, Vazquez-Benitez G, Shi WX, et al. Assessing the safety of influenza immunization during pregnancy: the Vaccine Safety Datalink. Am J Obstet Gynecol. 2012;207(3 Suppl):S47-S51. (Abstract only)

Klein NP, Lewis E, Fireman B, et al. Safety of Measles-Containing Vaccines in 1-Year-Old Children. Pediatrics. [Online ahead of print 2015 January 5]. (Abstract only)

Klein NP, Lewis E, Baxter R, et al. Measles-containing vaccines and febrile seizures in children age 4 to 6 years. Pediatrics. 2012;129(5):809-814.

Klein NP, Fireman B, Yih WK, et al. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics. 2010;126(1):e1-e8.

Klein NP, Massolo ML, Greene J, et al. Risk factors for developing apnea after immunization in the neonatal intensive care unit. Pediatrics. 2008;121(3):463-469.

Kramarz P, DeStefano F, Gargiullo PM, et al. Does influenza vaccination prevent asthma exacerbations in children? J Pediatr. 2001;138(3):306-310. (Abstract only)

Kramarz P, France EK, DeStefano F, et al. Population-based study of rotavirus vaccination and intussusception. Pediatr Infect Dis J. 2001;20(4):410-416. (Abstract only)

Kramarz P, DeStefano F, Gargiullo PM, et al. Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Arch Fam Med. 2000;9(7):617-623. (Abstract only)

Kramarz P, DeStefano F, Gargiullo PM, et al. Influenza vaccination in children with asthma in health maintenance organizations. Vaccine. 2000;18(21):2288-2294. (Abstract only)

Top of Page

Kulldorff M, Davis RL, Kolczak M, et al. A maximized sequential probability ratio test for drug and vaccine safety surveillance. Sequential Analysis. 2011;30(1):58-78. [PDF - 191 KB]

Kuppermann M, Nease RF, Jr., Ackerson LM, et al. Parents' preferences for outcomes associated with childhood vaccinations. Pediatr Infect Dis J. 2000;19(2):129-133. (Abstract only)

Lee GM, Greene SK, Weintraub ES, et al. H1N1 and seasonal influenza vaccine safety in the Vaccine Safety Datalink project. Am J Prev Med. 2011;41(2):121-128. (Abstract only)

Lewis E, Shinefield HR, Woodruff BA, et al. Safety of neonatal hepatitis B vaccine administration. Pediatr Infect Dis J. 2001;20(11):1049-1054. (Abstract only)

Lewis N, Black S, Weintraub E, et al. Rapid assessment of influenza vaccination coverage among HMO members--northern California influenza seasons, 2001-02 through 2004-05. MMWR Morb Mortal Wkly Rep. 2005;54(27):676-678.

Li L, Kulldorff M. A conditional maximized sequential probability ratio test for pharmacovigilance. Stat Med. 2010;29(2):284-295. (Abstract only)

Li R, Stewart B, Weintraub E, et al. Continuous sequential boundaries for vaccine safety surveillance. Stat Med. 2014 Aug 30;33(19):3387-3397. (Abstract only)

Lieberman P, Camargo CA, Jr., Bohlke K, et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol. 2006;97(5):596-602. (Abstract only)

Lieu TA, Kulldorff M, Davis RL, et al. Real-time vaccine safety surveillance for the early detection of adverse events. Med Care. 2007;45(10 Suppl 2):S89-S95. (Abstract only)

Lieu TA, Davis RL, Capra AM, et al. Variation in clinician recommendations for multiple injections during adoption of inactivated polio vaccine. Pediatrics. 2001;107(4):E49. (Abstract only)

Lieu TA, Black SB, Ray GT, et al. The hidden costs of infant vaccination. Vaccine. 2000;19(1):33-41. (Abstract only)

Lieu TA, Black SB, Takahashi H, et al. Varicella serology among school age children with a negative or uncertain history of chickenpox. Pediatr Infect Dis J. 1998;17(2):120-125. (Abstract only)

Lieu TA, Capra AM, Makol J, et al. Effectiveness and cost-effectiveness of letters, automated telephone messages, or both for underimmunized children in a health maintenance organization. Pediatrics. 1998;101(4):E3. (Abstract only)

Lieu TA, Black SB, Ray P, et al. Computer-generated recall letters for underimmunized children: how cost-effective? Pediatr Infect Dis J. 1997;16(1):28-33. (Abstract only)

Lieu TA, Black SB, Sorel ME, et al. Would better adherence to guidelines improve childhood immunization rates? Pediatrics. 1996;98(6 Pt 1):1062-1068. (Abstract only)

Lieu TA, Black SB, Ray P, et al. Risk factors for delayed immunization among children in an HMO. Am J Public Health. 1994;84(10):1621-1625.

Lin ND, Kleinman K, Chan KA, et al. Multiple vaccinations and the risk of medically attended fever. Vaccine. 2010;28(25):4169-4174. (Abstract only)

Lin ND, Kleinman K, Chan KA, et al. Variation in hepatitis B immunization coverage rates associated with provider practices after the temporary suspension of the birth dose. BMC Pediatr. 2006;6:31.

Lin ND, Kleinman K, Chan KA, et al. Impact of the introduction of pneumococcal conjugate vaccine on immunization coverage among infants. BMC Pediatr. 2005;5:43.

Lorick SA, Fishbein D, Weintraub E, et al. Uptake of meningococcal conjugate vaccine among adolescents in large managed care organizations, United States, 2005: Demand, supply and seasonality. BMC Infect Dis. 2009;9:175.

Top of Page

Maher JE, Mullooly JP, Drew L, et al. Infant vaccinations and childhood asthma among full-term infants. Pharmacoepidemiol Drug Saf. 2004;13(1):1-9. (Abstract only)

McCarthy NL, Gee J, Lin ND, et al. Evaluating the safety of influenza vaccine using a claims-based health system. Vaccine. 2013;31(50):5975-5982. (Abstract only)

McCarthy NL, Irving S, Donahue JG, et al. Vaccination coverage levels among children enrolled in the Vaccine Safety Datalink. Vaccine. 2013;31(49):5822-5826. (Abstract only)

McCarthy NL, Weintraub E, Vellozzi C, et al. Mortality rates and cause-of-death patterns in a vaccinated population. Am J Prev Med. 2013;45(1):91-97. (Abstract only)

McCarthy NL, Gee J, Weintraub E, et al. Monitoring vaccine safety using the Vaccine Safety Datalink: utilizing immunization registries for pandemic influenza. Vaccine. 2011;29(31):4891-4896. (Abstract only)

McClure DL, Xu S, Weintraub E, et al. An efficient statistical algorithm for a temporal scan statistic applied to vaccine safety analyses. Vaccine. 2012;30(27):3986-3991. (Abstract only)

McClure DL, Glanz JM, Xu S, et al. Comparison of epidemiologic methods for active surveillance of vaccine safety. Vaccine. 2008;26(26):3341-3345. (Abstract only)

McNeil MM, Gee J, Weintraub ES et al. The Vaccine Safety Datalink: Successes and challenges monitoring vaccine safety. Vaccine. 2014 Sep 22;32(42):5390-5398. (Abstract only)

Mell LK, Ogren DS, Davis RL, et al. Compliance with national immunization guidelines for children younger than 2 years, 1996-1999. Pediatrics. 2005;115(2):461-467. (Abstract only)

Mell LK, Davis RL, Mullooly JP, et al. Polio extraimmunization in children younger than 2 years after changes in immunization recommendations. Pediatrics. 2003;111(2):296-301. (Abstract only)

Mullooly J, Drew L, DeStefano F, et al. Quality assessments of HMO diagnosis databases used to monitor childhood vaccine safety. Methods Inf Med. 2004;43(2):163-170. (Abstract only)

Top of Page

Mullooly J, Drew L, DeStefano F, et al. Quality of HMO vaccination databases used to monitor childhood vaccine safety. Am J Epidemiol. 1999;149(2):186-194. [PDF - 45 KB]

Mullooly JP, Schuler R, Mesa J, et al. Wheezing lower respiratory disease and vaccination of premature infants. Vaccine. 2011;29(44):7611-7617. (Abstract only)

Mullooly JP, Donahue JG, DeStefano F, et al. Predictive value of ICD-9-CM codes used in vaccine safety research. Methods Inf Med. 2008;47(4):328-335. (Abstract only)

Mullooly JP, Bridges CB, Thompson WW, et al. Influenza- and RSV-associated hospitalizations among adults. Vaccine. 2007;25(5):846-855. (Abstract only)

Mullooly JP, Schuler R, Barrett M, et al. Vaccines, antibiotics, and atopy. Pharmacoepidemiol Drug Saf. 2007;16(3):275-288. (Abstract only)

Mullooly JP, Crane B, Chun C. Trivalent inactivated influenza vaccine safety in children: assessing the contribution of telephone encounters. Vaccine. 2006;24(13):2256-2263. (Abstract only)

Mullooly JP, Riedlinger K, Chun C, et al. Incidence of herpes zoster, 1997-2002. Epidemiol Infect. 2005;133(2):245-253. [PDF - 120 KB]

Mullooly JP, Maher JE, Drew L, et al. Evaluation of the impact of an HMO's varicella vaccination program on incidence of varicella. Vaccine. 2004;22(11-12):1480-1485. (Abstract only)

Mullooly JP, Pearson J, Drew L, et al. Wheezing lower respiratory disease and vaccination of full-term infants. Pharmacoepidemiol Drug Saf. 2002;11(1):21-30. (Abstract only)

Mullooly JP. Misclassification model for person-time analysis of automated medical care databases. Am J Epidemiol. 1996;144(8):782-792. [PDF - 714 KB]

Top of Page

Naleway AL, Irving SA, Henninger ML, et al. Safety of influenza vaccination during pregnancy: A review of subsequent maternal obstetric events and findings from two recent cohort studies. Vaccine. 2014;32(26):3122-3127. (Abstract only)

Naleway AL, Kurosky S, Henninger ML, et al. Vaccinations given during pregnancy, 2002-2009: a descriptive study. Am J Prev Med. 2014;46(2):150-157. (Abstract only)

Naleway AL, Gold R, Kurosky S, et al. Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink. Vaccine. 2013;31(27):2898-2903. (Abstract only)

Naleway AL, Gold R, Drew L, et al. Reported adverse events in young women following quadrivalent human papillomavirus vaccination. J Womens Health (Larchmt.). 2012;21(4):425-432. (Abstract only)

Naleway AL, Belongia EA, Donahue JG, et al. Risk of immune hemolytic anemia in children following immunization. Vaccine. 2009;27(52):7394-7397. (Abstract only)

Naleway AL, Belongia EA, Greenlee RT, et al. Eczematous skin disease and recall of past diagnoses: implications for smallpox vaccination. Ann Intern Med. 2003;139(1):1-7. (Abstract only)

Nelson JC, Shortreed SM, Yu O et al. Integrating database knowledge and epidemiological design to improve the implementation of data mining methods to evaluate vaccine safety in large healthcare databases. Stat Analysis Data Mining. [online ahead of print 2014 Aug 19]. (Abstract only)

Nelson JC, Yu O, Dominguez-Islas CP, et al. Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety study. Am J Epidemiol. 2013;177(2):131-141.

Nelson JC, Marsh T, Lumley T, et al. Validation sampling can reduce bias in health care database studies: an illustration using influenza vaccination effectiveness. J Clin Epidemiol. 2013;66(8 Suppl):S110-S121.

Nelson JC, Cook AJ, Yu O, et al. Methods for observational post-licensure medical product safety surveillance. Stat Methods Med Res. [Online ahead of print 2 Dec 2011]. (Abstract only)

Nelson JC, Bittner RC, Bounds L, et al. Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a vaccine safety datalink study. Am J Public Health. 2009;99(Suppl 2):S389-S397. (Abstract only)

Top of Page

Neuzil KM, Jackson LA, Nelson J, et al. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis. 2006;194(8):1032-1039.

Newcomer SR, Hambidge SJ, McClure DL, et al. Factors that may explain observed associations between trivalent influenza vaccination and gastrointestinal illness in young children. Vaccine. 2013;31(37):3894-3898. (Abstract only)

Niu MT, Rhodes P, Salive M, et al. Comparative safety of two recombinant hepatitis B vaccines in children: data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD). J Clin Epidemiol. 1998;51(6):503-510. (Abstract only)

Nordin JD, Kharbanda EO, Vazquez-Benitez G et al. Monovalent H1N1 influenza vaccine safety in pregnant women, risks for acute adverse events. Vaccine. 2014 Sep 3; 32(39):4985-4992. (Abstract only)

Nordin JD, Kharbanda EO, Vazquez Benitez G, et al. Maternal influenza vaccine and risks for preterm or small for gestational age birth. J Pediatr. 2014;164(5):1051-1057. (Abstract only)

Nordin JD, Parker ED, Vazquez-Benitez G, et al. Safety of the yellow fever vaccine: a retrospective study. J Travel Med. 2013;20(6):368-373. (Abstract only)

Nordin JD, Kharbanda EO, Benitez GV, et al. Maternal safety of trivalent inactivated influenza vaccine in pregnant women. Obstet Gynecol. 2013;121(3):519-525. (Abstract only)

O'Brien MA, Uyeki TM, Shay DK, et al. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics. 2004;113(3 Pt 1):585-593. (Abstract only)

Parashar UD, Holman RC, Bresee JS, et al. Epidemiology of diarrheal disease among children enrolled in four West Coast health maintenance organizations. Pediatr Infect Dis J. 1998;17(7):605-611. (Abstract only)

Patel MM, Haber P, Baggs J, et al. Intussusception and rotavirus vaccination: a review of the available evidence. Expert Rev Vaccines. 2009;8(11):1555-1564. (Abstract only)

Pearson DC, Thompson RS. Evaluation of Group Health Cooperative of Puget Sound's Senior Influenza Immunization Program. Public Health Rep. 1994;109(4):571-578. [PDF - 1.38 MB]

Top of Page

Price CS, Thompson WW, Goodson B, et al. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics. 2010;126(4):656-664.

Prosser LA, Bridges CB, Uyeki TM, et al. Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Emerg Infect Dis. 2006;12(10):1548-1558.

Prosser LA, Bridges CB, Uyeki TM, et al. Values for preventing influenza-related morbidity and vaccine adverse events in children. Health Qual Life Outcomes. 2005;3:18.

Qian L, Tseng HF, Sy LS, et al. Confounder adjustment in vaccine safety studies: comparing three offset terms for case-centered approach. Vaccine. 2013;31(2):431-435. (Abstract only)

Ray P, Black S, Shinefield H, et al. Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15-59 years of age. Vaccine. 2011;29(38):6592-6597. (Abstract only)

Ray P, Hayward J, Michelson D, et al. Encephalopathy after whole-cell pertussis or measles vaccination: lack of evidence for a causal association in a retrospective case-control study. Pediatr Infect Dis J. 2006;25(9):768-773. (Abstract only)

Ray P, Black S, Shinefield H, et al. Risk of chronic arthropathy among women after rubella vaccination. JAMA. 1997;278(7):551-556. (Abstract only)

Rowhani-Rahbar A, Baxter R, Rasgon B, et al. Epidemiologic and clinical features of Bell's palsy among children in northern California. Neuroepidemiology. 2012;38(4):252-258. (Abstract only)

Rowhani-Rahbar A, Fireman B, Lewis N, et al. Rowhani-Rahbar et al. respond to "Immunization and Bell's palsy in children." Am J Epidemiol. 2012;175(9):888-889.

Rowhani-Rahbar A, Klein NP, Lewis N, et al. Immunization and Bell's palsy in children: a case-centered analysis. Am J Epidemiol. 2012;175(9):878-885.

Top of Page

Salmon DA, Proschan M, Forshee R, et al. Association between Guillain-Barre syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet. 2013;381(9876):1461-1468. (Abstract only)

Schmidt MA, Gold R, Kurosky SK, et al. Uptake, coverage, and completion of quadrivalent human papillomavirus vaccine in the Vaccine Safety Datalink, July 2006-June 2011. J Adolesc Health. 2013;53(5):637-641. (Abstract only)

Schmidt MA, Crane B, Mullooly JP, et al. Frequency of medically attended events following rapid revaccination with trivalent inactivated influenza vaccine. Vaccine. 2010;28(49):7713-7715. (Abstract only)

Shui IM, Baggs J, Patel M, et al. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. JAMA. 2012;307(6):598-604. (Abstract only)

Shui IM, Rett MD, Weintraub E, et al. Guillain-Barré syndrome incidence in a large United States cohort (2000-2009). Neuroepidemiology. 2012;39(2):109-115. (Abstract only)

Shui IM, Shi P, Dutta-Linn MM, et al. Predictive value of seizure ICD-9 codes for vaccine safety research. Vaccine. 2009;27(39):5307-5312. (Abstract only)

Spector L, Groves F, DeStefano F, et al. Medically recorded allergies and the risk of childhood acute lymphoblastic leukaemia. Eur J Cancer. 2004;40(4):579-584. (Abstract only)

Sy LS, Liu IL, Solano Z, et al. Accuracy of influenza vaccination status in a computer-based immunization tracking system of a managed care organization. Vaccine. 2010. (Abstract only)

Tartof SY, Tseng HF, Liu IL,  et al. Inpatient admission for febrile seizure and subsequent outcomes do not differ in children with vaccine-associated versus non-vaccine associated febrile seizures. Vaccine. 2014;32(48):6408-14.

Tartof SY, Tseng HF, Liu AL, et al. Exploring the risk factors for vaccine-associated and non-vaccine associated febrile seizures in a large pediatric cohort. Vaccine. 2014;32(22):2574-2581. (Abstract only)

Tate JE, Curns AT, Cortese MM, et al. Burden of acute gastroenteritis hospitalizations and emergency department visits in US children that is potentially preventable by rotavirus vaccination: a probe study using the now-withdrawn rotashield vaccine. Pediatrics. 2009;123(3):744-749.

Thompson RS. What have HMOs learned about clinical prevention services? An examination of the experience at Group Health Cooperative of Puget Sound. Milbank Q. 1996;74(4):469-509. (Abstract only)

Thompson WW, Price C, Goodson B, et al. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med. 2007;357(13):1281-1292.

Tse A, Tseng HF, Greene SK, et al. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011. Vaccine. 2012;30(11):2024-2031. (Abstract only)

Tseng HF, Sy LS, Liu IL, et al. Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in children. Vaccine. 2013;31(22):2578-2583. (Abstract only)

Tseng HF, Sy LS, Qian L, et al. Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population. Clin Infect Dis. 2012;56(3):315-321.

Tseng HF, Liu A, Sy L, et al. Safety of zoster vaccine in adults from a large managed care cohort: a Vaccine Safety Datalink study. J Intern Med. 2011;271(5):510-520. (Abstract only)

Udovic SL, Lieu TA, Black SB, et al. Parent reports on willingness to accept childhood immunizations during urgent care visits. Pediatrics. 1998;102(4):E47. (Abstract only)

Verstraeten T, Davis RL, DeStefano F, et al. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics. 2003;112(5):1039-1048. (Abstract only)

Verstraeten T, Jumaan AO, Mullooly JP, et al. A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination. Pediatrics. 2003;112(2):e98-103. (Abstract only)

Verstraeten T, DeStefano F, Chen RT, et al. Vaccine safety surveillance using large linked databases: opportunities, hazards and proposed guidelines. Expert Rev Vaccines. 2003;2(1):21-29. (Abstract only)

Top of Page

Wassilak SG, Glasser JW, Chen RT, et al. Utility of large-linked databases in vaccine safety, particularly in distinguishing independent and synergistic effects. Ann NY Acad Sci. 1995;754:377-382. (No abstract available)

Wei F, Mullooly JP, Goodman M, et al. Identification and characteristics of vaccine refusers. BMC Pediatr. 2009;9:18.

Weinmann S, Chun C, Mullooly JP, et al. Laboratory diagnosis and characteristics of breakthrough varicella in children. J Infect Dis. 2008;197(Suppl 2):S132-S138.

Weintraub ES, Baggs J, Duffy J, et al. Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med. 2014;370(6):513-519. (Abstract only)

Xu S, Newcomer S, Nelson J, et al. Signal detection of adverse events with imperfect confirmation rates in vaccine safety studies using self-controlled case series design. Biom J. 2014;56(3):513-525. (Abstract only)

Xu S, Hambidge SJ, McClure DL, et al. A scan statistic for identifying optimal risk windows in vaccine safety studies using self-controlled case series design. Stat Med. 2013;32(19):3290-3299.

Xu S, Zeng C, Newcomer S, et al. Use of fixed effects models to analyze self-controlled case series data in vaccine safety studies. J Biom Biostat. 2012;Suppl 7:006.

Xu S, Gargiullo P, Mullooly J, et al. Fitting parametric and semi-parametric conditional poisson regression models with Cox's partial likelihood in self-controlled case series and matched cohort studies. Journal of Data Science. 2010;8:349-360. [PDF - 94 KB]

Xu S, Zhang L, Nelson JC, et al. Identifying optimal risk windows for self-controlled case series studies of vaccine safety. Stat Med. 2010;30(7):742-752. (Abstract only)

Yih WK, Weintraub E, Kulldorff M. No risk of Guillain-Barré syndrome found after meningococcal conjugate vaccination in two large cohort studies. Pharmacoepidemiol Drug Saf. 2012;21(12):1359-1360. (No abstract available)

Top of Page

Yih WK, Kulldorff M, Fireman BH, et al. Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project. Pediatrics. 2011;127(Suppl 1):S54-S64.

Yih WK, Nordin JD, Kulldorff M, et al. An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink. Vaccine. 2009;27(32):4257-4262. (Abstract only)

Yih WK, Lieu TA, Rego VH, et al. Attitudes of healthcare workers in U.S. hospitals regarding smallpox vaccination. BMC Public Health. 2003;3:20.

Young HA, Geier DA, Geier MR. Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink. J Neurol Sci. 2008; 271(1-2):110-118. (Abstract only)

Yu O, Bohlke K, Hanson CA, et al. Hepatitis B vaccine and risk of autoimmune thyroid disease: a Vaccine Safety Datalink study. Pharmacoepidemiol Drug Saf. 2007;16(7):736-745. (Abstract only)

Zangwill KM, Yeh SH, Wong EJ, et al. Paralytic syndromes in children: epidemiology and relationship to vaccination. Pediatr Neurol. 2010;42(3):206-212. (Abstract only)

Zeng C, Newcomer SR, Glanz JM, et al. Bias correction of risk estimates in vaccine safety studies with rare adverse events using a self-controlled case series design. Am J Epidemiol. 2013;178(12):1750-1759. (Abstract only)

Top of Page

Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    TTY: (888) 232-6348
  • Contact CDC–INFO The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #